Skip to main content
Year archive

BIOTRON LIMITED — 2017 filings

All 37 regulatory filings released by BIOTRON LIMITED (BIT) in 2017, sourced directly from the official regulator.

37 Filings
2017 Period
2017 filings (37)
Filing Released Lang
Appendix 3B 9 pages 95.1KB
Capital/Financing Update
2017-12-07 English
Resignation of a Director 3 pages 37.3KB
Board/Management Information
2017-11-19 English
AGM Presentation 19 pages 1.7MB
AGM Information
2017-11-19 English
Results of Meeting 2 pages 38.8KB
Declaration of Voting Results & Voting Rights Announcements
2017-11-19 English
Biotron Compounds Demonstrate Activity Against HBV 2 pages 43.3KB
Regulatory Filings
2017-11-14 English
$1.6 Million R&D Tax Incentive Received 1 page 37.6
Capital/Financing Update
2017-10-31 English
Response to ASX Price Query 5 pages 186.8KB
Regulatory Filings
2017-10-25 English
Annual Report and Notice of AGM/Proxy Form 55 pages 2.0MB
Annual Report FY 2017
2017-10-17 English
Appendix 4C - quarterly 5 pages 166.0KB
Interim / Quarterly Report Q1 2018
2017-10-12 English
Presentation to Investors 15 pages 3.1MB
Investor Presentation
2017-10-05 English
Appendix 4G and Corporate Governance Statement 20 pages 201.6KB
Governance Information
2017-08-27 English
Full Year Statutory Accounts 53 pages 586.4KB
Annual Report FY 2017
2017-08-27 English
BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited 2 pages 38.7KB
Regulatory Filings
2017-07-26 English
Appendix 3B 9 pages 95.1KB
Share Issue/Capital Change
2017-07-18 English
Appendix 4C - quarterly 5 pages 91.1KB
Interim / Quarterly Report Q4 2017
2017-07-12 English
Change of Director's Interest Notice 3 pages 83.3KB
Director's Dealing
2017-07-04 English
Change of Director's Interest Notices 11 pages 109.5KB
Director's Dealing
2017-06-27 English
Change of Director's Interest Notice 3 pages 83.1KB
Director's Dealing
2017-06-26 English
New Issue Oversubscribed 1 page 33.1KB
Capital/Financing Update
2017-06-22 English
Change of Director's Interest Notice 3 pages 83.0KB
Director's Dealing
2017-06-21 English
Change of Director's Interest Notice 3 pages 47.5KB
Director's Dealing
2017-06-18 English
BIT225 Phase 2 HIV-1 Clinical Trial Update 2 pages 48.1KB
Regulatory Filings
2017-06-14 English
Advisor appointed to advance commercialisation in China 2 pages 38.4KB
Capital/Financing Update
2017-06-08 English
Appendix 3B 14 pages 127.0KB
Capital/Financing Update
2017-05-24 English
Renounceable Issue 23 pages 2.1MB
Capital/Financing Update
2017-05-24 English
Prospectus 41 pages 175.3KB
Capital/Financing Update
2017-05-24 English
The Need for Drugs Targeting HIV-1 in Macophages 2 pages 67.1KB
Regulatory Filings
2017-04-30 English
Appendix 4C - quarterly 5 pages 90.9KB
Interim / Quarterly Report 9M 2017
2017-04-19 English
Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial 2 pages 42.4KB
Regulatory Filings
2017-04-10 English
Letter to Shareholders 3 pages 237.1KB
Regulatory Filings
2017-02-26 English
Half Yearly Report and Accounts 19 pages 257.2KB
Interim / Quarterly Report H1 2017
2017-02-23 English
Commencement of BIT225 Phase 2 HIV-1 Clinical Trial 2 pages 44.3KB
Regulatory Filings
2017-02-12 English
$1.6 Million R&D Tax Rebate Received 1 page 34.6KB
Capital/Financing Update
2017-02-12 English
BIT225 Accelerates HIV-1 Virus Reduction 2 pages 38.3KB
Regulatory Filings
2017-02-05 English
Appendix 4C - quarterly 5 pages 85.6KB
Interim / Quarterly Report Q2 2017
2017-01-15 English
Biotron Presents at Biotech Showcase 2017 22 pages 3.6MB
Investor Presentation
2017-01-12 English
Corrected Presentation to Biotech Showcase 2017 26 pages 3.8MB
Investor Presentation
2017-01-12 English